Sygnis Pharma completes rights offering

Sygnis Pharma AG (Xetra: LIO1), Heidelberg, Germany Business: Diagnostic Date completed: 10/28/13 Type: Rights offering Raised: €2.7 million ($3.7 million) Shares: 1 million Price: €2.65 Shares after ...